Editas Medicine (EDIT) Return on Equity (2016 - 2025)
Historic Return on Equity for Editas Medicine (EDIT) over the last 10 years, with Q3 2025 value amounting to 12.11%.
- Editas Medicine's Return on Equity fell 110800.0% to 12.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.11%, marking a year-over-year decrease of 110800.0%. This contributed to the annual value of 0.98% for FY2024, which is 5500.0% down from last year.
- According to the latest figures from Q3 2025, Editas Medicine's Return on Equity is 12.11%, which was down 110800.0% from 5.75% recorded in Q2 2025.
- In the past 5 years, Editas Medicine's Return on Equity ranged from a high of 0.27% in Q2 2021 and a low of 12.11% during Q3 2025
- Its 5-year average for Return on Equity is 1.55%, with a median of 0.52% in 2024.
- In the last 5 years, Editas Medicine's Return on Equity soared by 3200bps in 2021 and then crashed by -110800bps in 2025.
- Over the past 5 years, Editas Medicine's Return on Equity (Quarter) stood at 0.34% in 2021, then plummeted by -68bps to 0.57% in 2022, then rose by 25bps to 0.43% in 2023, then tumbled by -258bps to 1.53% in 2024, then tumbled by -691bps to 12.11% in 2025.
- Its Return on Equity was 12.11% in Q3 2025, compared to 5.75% in Q2 2025 and 2.55% in Q1 2025.